Home »
Academic Articles »
C »
Availability-Aware Multitask Learning for Robust Clinical Prediction from Incomplete Electronic Health Records
Availability-Aware Multitask Learning for Robust Clinical Prediction from Incomplete Electronic Health Records
Zhainagul Khamitova
(Department of Information Systems, L.N. Gumilyov Eurasian National University, Astana 010000, Kazakhstan)
Gulmira Omarova
(Department of Information Systems, L.N. Gumilyov Eurasian National University, Astana 010000, Kazakhstan)
Akerke Akanova
(School of Software Engineering, Astana IT University, Astana 010000, Kazakhstan)
Aliya Abdukarimova
(Department of Information Technology, K. Kulazhanov Kazakh University of Technology and Business, Astana 010000, Kazakhstan)
Kuanysh Kadirkulov
(Faculty of Information Systems and Technology, Esil University, Astana 010000, Kazakhstan)
Bagdat Satayev
(Department of Information Technology, K. Kulazhanov Kazakh University of Technology and Business, Astana 010000, Kazakhstan)
Aliya Beissegul
(Laboratory Information System (LIS) “SmartLab” Kazakhstan, Astana 010000, Kazakhstan)
Abdugani Kholbekov
(Department of Sociology, National University of Uzbekistan, Named After Mirzo Ulugbek, Tashkent 100174, Uzbekistan)
Gulnoz Dzhiyanmuratova
(Department of Sociology, National University of Uzbekistan, Named After Mirzo Ulugbek, Tashkent 100174, Uzbekistan)
Aizat Amirbay
(Department of Information Systems, L.N. Gumilyov Eurasian National University, Astana 010000, Kazakhstan)
Journal: Computers
•
• MDPI AG
• ISSN: 2073-431X
Abstract
This study presents NORIA, an availability-aware multitask learning framework for clinical prediction from incomplete electronic health records (EHRs). We analyzed a public dataset of 77,724 patients and 107 numerical features. To prevent temporal leakage, predictors were grouped by availability, and training-only feature selection identified three baseline and two first-year variables. NORIA jointly predicts baseline and updated glycemic control, an HbA1c change index, and 21 medication labels using shared representations, masked training, and stage-specific prediction updates. Comparators included classical machine learning, gradient boosting, deep tabular models, and multitask architectures (MMoE and PLE). On the internal test set, NORIA achieved AUROCs of 0.8554 and 0.8888 for baseline and updated glycemic control, respectively, and medication macro-AP of 0.1854 versus 0.1879 for CatBoost. The predefined medication improvement criterion was not met. With 20% of baseline features artificially masked, updated-control AUROC declined by 0.0271 for NORIA, versus 0.0510 for CatBoost and 0.0542 for FT-Transformer. Ablation analyses indicated that masked training provided the clearest robustness benefit. NORIA thus demonstrated competitive accuracy and robustness in selected simulated missing-data scenarios, without establishing overall superiority.